Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H24N4O |
| Molecular Weight | 372.4629 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C[C@H]2CCN([C@H]2C1)C3=CC=C(C=C3)C4=CC=C(C=C4)N5N=CC=CC5=O
InChI
InChIKey=GNIRITULTPTAQW-KNQAVFIVSA-N
InChI=1S/C23H24N4O/c1-25-15-19-12-14-26(22(19)16-25)20-8-4-17(5-9-20)18-6-10-21(11-7-18)27-23(28)3-2-13-24-27/h2-11,13,19,22H,12,14-16H2,1H3/t19-,22+/m1/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Safety, tolerability and pharmacokinetics of the histamine H3 receptor antagonist, ABT-288, in healthy young adults and elderly volunteers. | 2013-05 |
|
| Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonist. | 2012-10 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
948845-91-8
Created by
admin on Mon Mar 31 21:09:32 GMT 2025 , Edited by admin on Mon Mar 31 21:09:32 GMT 2025
|
PRIMARY | |||
|
100000175498
Created by
admin on Mon Mar 31 21:09:32 GMT 2025 , Edited by admin on Mon Mar 31 21:09:32 GMT 2025
|
PRIMARY | |||
|
5MEI1M3NHH
Created by
admin on Mon Mar 31 21:09:32 GMT 2025 , Edited by admin on Mon Mar 31 21:09:32 GMT 2025
|
PRIMARY | |||
|
24743471
Created by
admin on Mon Mar 31 21:09:32 GMT 2025 , Edited by admin on Mon Mar 31 21:09:32 GMT 2025
|
PRIMARY | |||
|
DB15192
Created by
admin on Mon Mar 31 21:09:32 GMT 2025 , Edited by admin on Mon Mar 31 21:09:32 GMT 2025
|
PRIMARY |
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD
